FDA Rejection of Moderna Flu Shot Raises Questions for Vaccine Development

The Food and Drug Administration's decision to reject Moderna's new flu shot has sparked discussions about the future trajectory of vaccine innovation and approval processes.

15 Feb, 13:05 — 15 Feb, 13:05

Coverage (1 source)

NPR15 Feb, 13:05

What the FDA's rejection of Moderna's flu shot means for the future of vaccines

The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.

By Sydney Lupkin

Read at source →